Details of the Drug Formulations

General Information of Drug (ID: DMK08L3)

• Drug Name: Amifampridine Drug Info
• Synonyms: 3,4-DIAMINOPYRIDINE; pyridine-3,4-diamine; 3,4-Pyridinediamine; Firdapse; Diamino-3,4 pyridine; 4,5-Diaminopyridine; 3,4-DAP; SC10; amifampridin; Zenas; UNII-RU4S6E2G0J; EINECS 200-220-9; NSC 521760; BRN 0110232; RU4S6E2G0J; OYTKINVCDFNREN-UHFFFAOYSA-N; WT559; NCGC00167560-01; SMR000752913

Indication

Disease Entry	ICD 11	Status	REF
LambertEaton myasthenic syndrome	8C62	Approved	[1]

• Cross-matching ID:
  PubChem CID: 5918
  ChEBI ID: CHEBI:135948
  CAS Number: 54-96-6
  TTD ID: D0HE0Y
  INTEDE ID: DR1747
  ACDINA ID: D00831

Full List of Drug Formulations Containing This Drug

Amifampridine 10 mg tablet

Company	Formulation ID	FDA Description
Jacobus Pharmaceutical	F23620	Colloidal Silicon Dioxide; Dibasic Calcium Phosphate Dihydrate; Magnesium Stearate; Microcrystalline Cellulose; Sodium Starch Glycolate
Catalyst Pharmaceuticals	F23619	Calcium Stearate; Colloidal Silicon Dioxide; Microcrystalline Cellulose

References

• [1] 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.